CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Natera, Inc. - NTRA CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024068%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.001846%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 27.35-59.75
Average Volume (10 days) 1.44M
Average Volume (3 months) 28.47M
Market Cap 6.31B
P/E Ratio -100.00K
Shares Outstanding 113.29M
Revenue 820.22M
EPS -5.57
Dividend (Yield %) N/A
Beta 1.19
Next Earnings Date May 3, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Natera, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 625.486 391.005 302.328 257.654 209.625
Revenue 625.486 391.005 302.328 257.654 209.625
Cost of Revenue, Total 318.418 203.62 175.47 166.055 139.596
Gross Profit 307.068 187.385 126.858 91.599 70.029
Total Operating Expense 1093.66 613.13 418.615 372.282 344.966
Selling/General/Admin. Expenses, Total 511.034 303.627 204.476 154.872 155.306
Research & Development 264.208 100.035 51.357 51.355 50.064
Operating Income -468.174 -222.125 -116.287 -114.628 -135.341
Interest Income (Expense), Net Non-Operating -8.305 -15.082 -10.693 -10.476 -4.213
Other, Net 5.381 7.562 4.152 -2.729 2.38
Net Income Before Taxes -471.098 -229.645 -122.828 -127.833 -137.174
Net Income After Taxes -471.716 -229.743 -124.827 -128.154 -137.628
Net Income Before Extra. Items -471.716 -229.743 -124.827 -128.154 -137.628
Net Income -471.716 -229.743 -124.827 -128.154 -137.628
Income Available to Common Excl. Extra. Items -471.716 -229.743 -124.827 -128.154 -137.628
Income Available to Common Incl. Extra. Items -471.716 -229.743 -124.827 -128.154 -137.628
Diluted Net Income -471.716 -229.743 -124.827 -128.154 -137.628
Diluted Weighted Average Shares 90.558 81.011 69.555 57.848 53.312
Diluted EPS Excluding Extraordinary Items -5.20899 -2.83595 -1.79465 -2.21536 -2.58156
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -5.20899 -2.78903 -1.91322 -2.21536 -2.58156
Total Extraordinary Items 0
Unusual Expense (Income) 0 5.848 -12.688
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 194.133 173.028 158.116 142.026 152.316
Revenue 194.133 173.028 158.116 142.026 152.316
Cost of Revenue, Total 103.215 94.122 81.371 76.112 66.813
Gross Profit 90.918 78.906 76.745 65.914 85.503
Total Operating Expense 331.263 312.694 308.313 257.32 215.333
Selling/General/Admin. Expenses, Total 147.634 146.761 128.485 127.456 108.332
Research & Development 80.414 71.811 98.457 53.752 40.188
Operating Income -137.13 -139.666 -150.197 -115.294 -63.017
Interest Income (Expense), Net Non-Operating -2.087 -2.079 -2.078 -2.075 -2.073
Other, Net 0.801 1.151 1.274 1.585 1.371
Net Income Before Taxes -138.416 -140.594 -151.001 -115.784 -63.719
Net Income After Taxes -138.595 -140.564 -151.273 -116.026 -63.853
Net Income Before Extra. Items -138.595 -140.564 -151.273 -116.026 -63.853
Net Income -138.595 -140.564 -151.273 -116.026 -63.853
Income Available to Common Excl. Extra. Items -138.595 -140.564 -151.273 -116.026 -63.853
Income Available to Common Incl. Extra. Items -138.595 -140.564 -151.273 -116.026 -63.853
Diluted Net Income -138.595 -140.564 -151.273 -116.026 -63.853
Diluted Weighted Average Shares 95.578 94.842 92.558 88.077 86.689
Diluted EPS Excluding Extraordinary Items -1.45007 -1.48209 -1.63436 -1.31732 -0.73658
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -1.45007 -1.48209 -1.63436 -1.31732 -0.73658
Unusual Expense (Income) 0 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 1093.14 862.663 523.167 240.518 180.625
Cash and Short Term Investments 914.282 737.274 440.991 153.868 118.867
Cash & Equivalents 84.386 48.668 61.926 46.407 12.62
Short Term Investments 829.896 688.606 379.065 107.461 106.247
Total Receivables, Net 122.074 78.565 53.351 62.223 44.089
Accounts Receivable - Trade, Net 122.074 78.565 53.351 62.223 44.089
Total Inventory 26.909 20.031 12.394 13.633 8.998
Prepaid Expenses 29.645 26.606 16.376 6.197 8.612
Other Current Assets, Total 0.228 0.187 0.055 4.597 0.059
Total Assets 1236.49 932.153 582.656 268.171 214.613
Property/Plant/Equipment, Total - Net 124.529 54.747 47.013 24.336 29.667
Property/Plant/Equipment, Total - Gross 143.942 104.801 88.537 58.633 56.652
Accumulated Depreciation, Total -19.413 -50.054 -41.524 -34.297 -26.985
Other Long Term Assets, Total 18.82 14.743 12.476 3.317 4.321
Total Current Liabilities 218.956 199.053 179.874 113.981 105.561
Accounts Payable 27.206 8.096 8.604 14.587 8.529
Accrued Expenses 114.854 71.689 54.03 33.843 35.558
Notes Payable/Short Term Debt 50.052 50.054 50.123 0 0
Current Port. of LT Debt/Capital Leases 50.153 50.112
Other Current Liabilities, Total 26.844 69.214 67.117 15.398 11.362
Total Liabilities 583.183 445.917 303.945 236.009 189.196
Total Long Term Debt 280.394 202.493 73.656 73.357 73.065
Other Liabilities, Total 83.833 44.371 50.415 48.671 10.57
Total Equity 653.304 486.236 278.711 32.162 25.417
Preferred Stock - Non Redeemable, Net 0
Common Stock 0.01 0.009 0.008 0.007 0.006
Additional Paid-In Capital 2050.42 1411.29 976.955 607.236 472.552
Retained Earnings (Accumulated Deficit) -1394.84 -929.318 -699.171 -574.529 -446.375
Other Equity, Total -2.287 4.259 0.919 -0.552 -0.766
Total Liabilities & Shareholders’ Equity 1236.49 932.153 582.656 268.171 214.613
Total Common Shares Outstanding 95.14 86.223 78.005 62.083 54.04
Long Term Debt 280.394 202.493 73.656 73.357 73.065
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 980.226 1093.14 1191.22 739.888 791.403
Cash and Short Term Investments 751.958 914.282 1023.7 580.243 653.572
Cash & Equivalents 158.298 84.386 95.103 62.811 65.126
Short Term Investments 593.66 829.896 928.596 517.432 588.446
Total Receivables, Net 167.862 122.074 110.416 100.13 87.562
Accounts Receivable - Trade, Net 167.862 122.074 110.416 100.13 87.562
Total Inventory 25.048 26.909 28.022 28.409 23.676
Prepaid Expenses 35.13 29.645 28.858 30.878 26.43
Other Current Assets, Total 0.228 0.228 0.228 0.228 0.163
Total Assets 1144.66 1236.49 1311.37 849.956 893.512
Property/Plant/Equipment, Total - Net 142.762 124.529 106.949 97.221 89.703
Property/Plant/Equipment, Total - Gross 165.177 143.942 165.263 152.538 142.306
Accumulated Depreciation, Total -22.415 -19.413 -58.314 -55.317 -52.603
Other Long Term Assets, Total 21.676 18.82 13.202 12.847 12.406
Total Current Liabilities 231.072 218.956 199.714 197.988 166.969
Accounts Payable 18.07 27.206 8.181 20.307 4.682
Accrued Expenses 130.919 114.854 114.18 93.183 81.711
Notes Payable/Short Term Debt 50.055 50.052 50.049 50.049 50.052
Other Current Liabilities, Total 32.028 26.844 27.304 34.449 30.524
Total Liabilities 602.329 583.183 552.357 550.846 521.067
Total Long Term Debt 280.706 280.394 280.085 279.777 279.471
Long Term Debt 280.706 280.394 280.085 279.777 279.471
Other Liabilities, Total 90.551 83.833 72.558 73.081 74.627
Total Equity 542.335 653.304 759.017 299.11 372.445
Common Stock 0.01 0.01 0.01 0.009 0.009
Additional Paid-In Capital 2089.66 2050.42 2011.79 1399.66 1356.21
Retained Earnings (Accumulated Deficit) -1533.43 -1394.84 -1254.27 -1103 -986.973
Other Equity, Total -13.904 -2.287 1.491 2.441 3.197
Total Liabilities & Shareholders’ Equity 1144.66 1236.49 1311.37 849.956 893.512
Total Common Shares Outstanding 96.259 95.14 94.538 88.498 87.43
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -471.716 -229.743 -124.827 -128.154 -137.628
Cash From Operating Activities -335.236 -182.512 -63.444 -70.581 -97.825
Cash From Operating Activities 11.254 8.613 7.73 7.501 7.143
Non-Cash Items 171.299 77.748 26.452 22.916 13.05
Cash Taxes Paid 0.283 0.067 2.154 0.332 0.177
Cash Interest Paid 7.077 3.296 12.455 7.914 3.568
Changes in Working Capital -46.073 -39.13 27.201 27.156 19.61
Cash From Investing Activities -205.193 -331.461 -266.353 -5.161 13.784
Capital Expenditures -49.588 -19.604 -4.968 -3.88 -9.867
Other Investing Cash Flow Items, Total -155.605 -311.857 -261.385 -1.281 23.651
Cash From Financing Activities 576.188 500.847 340.774 113.725 80.372
Issuance (Retirement) of Stock, Net 576.188 301.288 340.774 113.725 5.659
Issuance (Retirement) of Debt, Net 0 199.559 0 0 75
Net Change in Cash 35.759 -13.126 10.977 37.983 -3.669
Financing Cash Flow Items 0 -0.287
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -138.595 -471.716 -331.152 -179.879 -63.853
Cash From Operating Activities -137.277 -335.236 -236.5 -145.439 -74.876
Cash From Operating Activities 3.002 11.254 8.259 5.262 2.549
Non-Cash Items 40.865 171.299 136.312 68.849 28.676
Cash Interest Paid 0.159 7.077 3.69 3.538 0.152
Changes in Working Capital -42.549 -46.073 -49.919 -39.671 -42.248
Cash From Investing Activities 207.033 -205.193 -284.697 146.709 86.74
Capital Expenditures -15.885 -49.588 -36.298 -18.891 -10.26
Other Investing Cash Flow Items, Total 222.918 -155.605 -248.399 165.6 97
Cash From Financing Activities 4.156 576.188 567.673 12.914 4.57
Issuance (Retirement) of Stock, Net 4.156 576.188 567.673 12.914 4.57
Net Change in Cash 73.912 35.759 46.476 14.184 16.434
Issuance (Retirement) of Debt, Net 0 0 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.7594 9923131 1628200 2022-12-31 LOW
Fred Alger Management, LLC Investment Advisor/Hedge Fund 7.9205 8972823 191477 2022-12-31 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.2045 4763130 715214 2022-12-31 LOW
Samlyn Capital, LLC Hedge Fund 3.8755 4390372 2113236 2022-12-31 HIGH
JP Morgan Asset Management Investment Advisor 3.739 4235761 101390 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.1533 3572262 764812 2022-12-31 LOW
Sofinnova Investments, Inc Venture Capital 2.7369 3100560 -2400 2022-12-31 MED
Citadel Advisors LLC Hedge Fund 2.6914 3048948 884865 2022-12-31 HIGH
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.4544 2780428 1886903 2022-12-31 LOW
Eversept Partners, LP Hedge Fund 2.371 2685959 1260357 2022-12-31 MED
RTW Investments L.P. Investment Advisor/Hedge Fund 2.3033 2609283 400000 2022-12-31 LOW
Kynam Capital Management LP Hedge Fund 2.2979 2603207 584847 2022-12-31 HIGH
Principal Global Investors (Equity) Investment Advisor 1.7724 2007860 867205 2022-12-31 LOW
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 1.7181 1946353 441200 2022-12-31 LOW
Avidity Partners Management LP Hedge Fund 1.5879 1798900 63900 2022-12-31 HIGH
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.5711 1779828 184128 2022-12-31 LOW
Braidwell LP Hedge Fund 1.4309 1621012 1621012 2022-12-31
D. E. Shaw & Co., L.P. Hedge Fund 1.3493 1528566 -53493 2022-12-31 MED
Marshall Wace LLP Investment Advisor/Hedge Fund 1.3171 1492125 262940 2022-12-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3059 1479376 217067 2022-12-31 LOW

Start a global, multi-asset portfolio with an award-winning platform

Trade now Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Natera, Inc. Company profile

About Natera Inc

Natera, Inc. is a diagnostics company. The Company is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. The Company’s cell-free DNA (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Pre-implantation Genetics (Spectrum), Anora Miscarriage Test (Anora), Non-Invasive Paternity Testing (PAT) and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Natera Inc revenues increased 60% to $625.5M. Net loss increased from $229.7M to $471.7M. Revenues reflect Insurance carriers segment increase of 64% to $492.6M, Laboratory and other partners segment increase of 72% to $100M, United States segment increase of 62% to $590.9M, Europe, Middle East, India, Africa segment increase of 43% to $20.4M. Higher net loss reflects Selling.

Industry: Laboratory Diagnostic & Testing Substances

13011 Mccallen Pass
Building A Suite 100
AUSTIN
TEXAS 78753
US

Income Statement

  • Annual
  • Quarterly

People also watch

Gold

1,978.85 Price
-0.760% 1D Chg, %
Long position overnight fee -0.0179%
Short position overnight fee 0.0097%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

0.46 Price
+8.550% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00356

US100

12,798.80 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0241%
Short position overnight fee 0.0018%
Overnight fee time 21:00 (UTC)
Spread 3.0

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee -0.0025%
Overnight fee time 21:00 (UTC)
Spread 0.03

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading